Cocrystal Pharma, Inc. (COCP)
1.07
+0.01
(+0.94%)
USD |
NASDAQ |
Oct 08, 16:00
Cocrystal Pharma Price : 1.07 for Oct. 8, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 1.06 | 1.100 | 1.06 | 1.07 | 29032.00 |
| Oct 07, 2026 | 1.11 | 1.11 | 1.06 | 1.06 | 30212.00 |
| Oct 06, 2026 | 1.11 | 1.13 | 1.10 | 1.11 | 28500.00 |
| Oct 05, 2026 | 1.182 | 1.182 | 1.11 | 1.11 | 41304.00 |
| Oct 02, 2026 | 1.17 | 1.17 | 1.14 | 1.145 | 13713.00 |
| Oct 01, 2026 | 1.177 | 1.18 | 1.12 | 1.14 | 68044.00 |
| Sep 30, 2026 | 1.14 | 1.19 | 1.12 | 1.15 | 12665.00 |
| Sep 29, 2026 | 1.24 | 1.24 | 1.100 | 1.12 | 121019.0 |
| Sep 28, 2026 | 1.19 | 1.22 | 1.151 | 1.21 | 32115.00 |
| Sep 25, 2026 | 1.180 | 1.180 | 1.142 | 1.17 | 13384.00 |
| Sep 24, 2026 | 1.209 | 1.210 | 1.13 | 1.15 | 48044.00 |
| Sep 23, 2026 | 1.17 | 1.280 | 1.16 | 1.19 | 26056.00 |
| Sep 22, 2026 | 1.21 | 1.28 | 1.19 | 1.19 | 69025.00 |
| Sep 21, 2026 | 1.20 | 1.25 | 1.19 | 1.19 | 41132.00 |
| Sep 18, 2026 | 1.14 | 1.25 | 1.14 | 1.21 | 176485.0 |
| Sep 17, 2026 | 1.14 | 1.150 | 1.121 | 1.14 | 13822.00 |
| Sep 16, 2026 | 1.13 | 1.173 | 1.11 | 1.14 | 46846.00 |
| Sep 15, 2026 | 1.21 | 1.23 | 1.121 | 1.14 | 33986.00 |
| Sep 14, 2026 | 1.27 | 1.27 | 1.17 | 1.17 | 23073.00 |
| Sep 11, 2026 | 1.26 | 1.285 | 1.215 | 1.24 | 58539.00 |
| Sep 10, 2026 | 1.26 | 1.276 | 1.22 | 1.23 | 53602.00 |
| Sep 09, 2026 | 1.18 | 1.29 | 1.175 | 1.24 | 111347.0 |
| Sep 08, 2026 | 1.15 | 1.20 | 1.124 | 1.18 | 61385.00 |
| Sep 04, 2026 | 1.12 | 1.14 | 1.10 | 1.13 | 43422.00 |
| Sep 03, 2026 | 1.16 | 1.16 | 1.12 | 1.13 | 29247.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CNBX Pharmaceuticals, Inc. | 0.0002 |
| Arvinas, Inc. | 7.51 |
| Fulcrum Therapeutics, Inc. | 3.75 |
| Definium Therapeutics, Inc. | 34.18 |
| LeonaBio, Inc. | 5.75 |
Price Related Metrics
| PS Ratio | 42.43 |
| Price to Book Value | 14.13 |
| Earnings Yield | -70.91% |
| Market Cap | 14.75M |